TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Nurse Practitioners
KW - Rural Population
KW - scope of practice
KW - United States
KW - Comprehensive Addiction and Recovery Act
KW - Buprenorphine prescribing
KW - scope-of-practice regulations
AU - T. Nguyen
AU - U. Muench
AU - B. Andraka-Christou
AU - K. Simon
AU - W. D. Bradford
AU - J. Spetz
A1 - 
AB - This article examines the relationship between federal regulations, state scope-of-practice regulations on nurse practitioners (NPs), and buprenorphine prescribing patterns using pharmacy claims data from Optum's deidentified Clinformatics Data Mart between January 2015 and September 2018. The county-level proportion of patients filling prescriptions written by NPs was low even after the 2016 Comprehensive Addiction and Recovery Act (CARA), 2.7% in states that did not require physician oversight of NPs, and 1.1% in states that did. While analyses in rural counties showed higher rates of buprenorphine prescriptions written by NPs, rates were still considerably low: 3.7% in states with less restrictive regulations and 1.1% in other states. These results indicate that less restrictive scope-of-practice regulations are associated with greater NP prescribing following CARA. The small magnitude of the changes indicates that federal attempts to expand treatment access through CARA have been limited.
AD - University of Michigan, Ann Arbor, MI, USA.; University of California, San Francisco, CA, USA.; University of Central Florida, Orlando, FL, USA.; Indiana University, Bloomington, IN, USA.; National Bureau of Economic Research, Cambridge, MA, USA.; University of Georgia, Athens, GA, USA.; University of California, San Francisco, CA, USA.
BT - Medical care research and review : MCRR
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
CP - 2
DO - 10.1177/10775587211004311
IS - 2
JF - Medical care research and review : MCRR
LA - eng
M1 - Journal Article
N2 - This article examines the relationship between federal regulations, state scope-of-practice regulations on nurse practitioners (NPs), and buprenorphine prescribing patterns using pharmacy claims data from Optum's deidentified Clinformatics Data Mart between January 2015 and September 2018. The county-level proportion of patients filling prescriptions written by NPs was low even after the 2016 Comprehensive Addiction and Recovery Act (CARA), 2.7% in states that did not require physician oversight of NPs, and 1.1% in states that did. While analyses in rural counties showed higher rates of buprenorphine prescriptions written by NPs, rates were still considerably low: 3.7% in states with less restrictive regulations and 1.1% in other states. These results indicate that less restrictive scope-of-practice regulations are associated with greater NP prescribing following CARA. The small magnitude of the changes indicates that federal attempts to expand treatment access through CARA have been limited.
PY - 2022
SN - 1552-6801; 1077-5587; 1077-5587
SP - 290
EP - 298
EP - 
T1 - The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill
T2 - Medical care research and review : MCRR
TI - The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U2 - 33792414
U3 - 10.1177/10775587211004311
VL - 79
VO - 1552-6801; 1077-5587; 1077-5587
Y1 - 2022
Y2 - Apr
ER -